Joel Greenblatt Bausch Health Companies Inc. Transaction History

Gotham Asset Management, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $184,198 - $288,910	-29,331 Reduced 39.86%	44,247 $358,000
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $123,115 - $160,312	-20,216 Reduced 21.55%	73,578 $462,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $32,518 - $65,391	-7,100 Reduced 7.04%	93,794 $646,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $584,109 - $1.96 Million	82,735 Added 455.61%	100,894 $843,000
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $149,364 - $192,167	6,915 Added 61.5%	18,159 $415,000
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $258,612 - $326,188	11,244 New	11,244 $310,000
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $578,992 - $690,231	-21,108 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $451,077 - $725,693	21,108 New	21,108 $670,000
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $171,283 - $231,716	-11,511 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $153,211 - $236,090	11,511 New	11,511 $211,000
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $1.49 Million - $3.47 Million	-114,815 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $1.58 Million - $2.68 Million	-83,888 Reduced 42.22%	114,815 $3.44 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $690,606 - $848,704	-33,075 Reduced 14.27%	198,703 $4.34 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $4.76 Million - $6.13 Million	231,778 New	231,778 $5.85 Million
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $140,343 - $225,313	-7,956 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $164,211 - $204,230	7,956 New	7,956 $204,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.